Hayden Michael R

Reported to SECin USFilings at 2 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 7
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
AbCellera Biologics Inc.—Open-market buy$570,44253,613 sharesAug 24, 2026AbCellera Biologics Inc.$570,442Buy · Aug 24Open-market buy53,613Aug 24, 2026
AbCellera Biologics Inc.—Open-market buy$481,03346,387 sharesAug 14, 2026AbCellera Biologics Inc.$481,033Buy · Aug 14Open-market buy46,387Aug 14, 2026
AbCellera Biologics Inc.—Giftnothing paid50,000 sharesAug 13, 2026AbCellera Biologics Inc.nothing paidGift · Aug 13Gift50,000Aug 13, 2026
IONIS PHARMACEUTICALS INC—Open-market buy$258,0005,000 sharesJul 31, 2026IONIS PHARMACEUTICALS INC$258,000Buy · Jul 31Open-market buy5,000Jul 31, 2026
IONIS PHARMACEUTICALS INC—Open-market buy$800,70015,000 sharesJul 31, 2026IONIS PHARMACEUTICALS INC$800,700Buy · Jul 31Open-market buy15,000Jul 31, 2026